Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion

CNS Spectrums

Volumn 13, Issue 6, 2008, Pages 459-460

  Hollander, Eric ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Seaver and New York Autism Center of Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ARIPIPRAZOLE; DNA; ENDOTOXIN; ESCITALOPRAM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; NEUROTRANSMITTER; PLACEBO; VARENICLINE;

ANXIETY DISORDER; AUTISM; BIPOLAR DISORDER; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOGENETICS; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; GENERALIZED ANXIETY DISORDER; HEREDITY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MENTAL DEFICIENCY; MENTAL DISEASE; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; PROTEIN DEFECT; PSYCHOSIS; RESTLESSNESS; RISK FACTOR; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SMOKING CESSATION; THORAX PAIN; TOBACCO DEPENDENCE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 46949109197     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900016679     Document Type: Editorial

References (0)